Intensive Care Medicine

, Volume 40, Issue 5, pp 640–653

The intensive care management of acute ischemic stroke: an overview

  • Matthew A. Kirkman
  • Giuseppe Citerio
  • Martin Smith



Acute ischemic stroke (AIS) is a leading cause of morbidity and mortality worldwide. In part due to the availability of more aggressive treatments, increasing numbers of patients with AIS are being admitted to the intensive care unit (ICU). Despite the availability of consensus guidance for the general management of AIS, there is little evidence to support its ICU management. The purpose of this article is to provide a contemporary perspective, and our recommendations, on the ICU management of AIS.


We reviewed the current general AIS guidelines provided by the European Stroke Organisation, the American Stroke Association, and the UK National Institute for Health and Care Excellence, as well as the wider literature, for the data most relevant to the ICU management of AIS.


There are four interventions in AIS supported by class I evidence: care on a stroke unit, intravenous tissue plasminogen activator within 4.5 h of stroke onset, aspirin within 48 h of stroke onset, and decompressive craniectomy for supratentorial malignant hemispheric cerebral infarction. However, robust evidence for specific AIS management principles in the ICU setting is weak. Management principles currently focus on airway and ventilation management, hemodynamic and fluid optimization, fever and glycemic control, management of anticoagulation, antiplatelet and thromboprophylaxis therapy, control of seizures and surgical interventions for malignant middle cerebral artery and cerebellar infarctions.


We have provided our recommendations for the principles of ICU management of AIS, based on the best available current evidence. Encouragement of large-scale recruitment of patients with AIS into clinical trials should aid the development of robust evidence for the benefit of different interventions in the ICU on outcome.


Acute ischemic stroke Endovascular therapy Management Neurocritical care Thrombolysis 

Supplementary material

134_2014_3266_MOESM1_ESM.doc (56 kb)
Supplementary material 1 (DOC 56 kb)


  1. 1.
    Lopez AD, Mathers CD, Ezzati M et al (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757. doi:10.1016/s0140-6736(06)68770-9 PubMedCrossRefGoogle Scholar
  2. 2.
    Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612–1623. doi:10.1016/S0140-6736(08)60694-7 PubMedCrossRefGoogle Scholar
  3. 3.
    Lees KR, Bluhmki E, von Kummer R et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695–1703. doi:10.1016/s0140-6736(10)60491-6 PubMedCrossRefGoogle Scholar
  4. 4.
    European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457–507. doi:10.1159/000131083 CrossRefGoogle Scholar
  5. 5.
    Jauch EC, Saver JL, Adams HPJ et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. doi:10.1161/STR.0b013e318284056a PubMedCrossRefGoogle Scholar
  6. 6.
    National Collaborating Centre for Chronic Conditions (2008) Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). Royal College of Physicians, LondonGoogle Scholar
  7. 7.
    Zazulia AR (2009) Critical care management of acute ischemic stroke. Continuum (Minneap Minn) 15:68–82Google Scholar
  8. 8.
    Bollaert P-E, Vinatier I, Orlikowski D, Meyer P (2010) Prise en charge de l’accident vasculaire cérébral chez l’adulte et l’enfant par le réanimateur (nouveau-né exclu), (hémorragie méningée exclue): recommandations formalisées d’experts sous l’égide de la Société de réanimation de langue française, Avec la participation du groupe francophone de réanimation et urgences pédiatriques (GFRUP), de la société française neurovasculaire (SFNV), de l’association de neuro-anesthésie et réanimation de langue française (ANARLF), de l’agence de la biomédecine (ABM). Reanimation 19:471–478. doi:10.1016/j.reaurg.2010.06.005 CrossRefGoogle Scholar
  9. 9.
    Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391–397PubMedCrossRefGoogle Scholar
  10. 10.
    Sutherland BA, Minnerup J, Balami JS et al (2012) Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke 7:407–418. doi:10.1111/j.1747-4949.2012.00770.x PubMedCrossRefGoogle Scholar
  11. 11.
    Petty GW, Brown RDJ, Whisnant JP et al (1999) Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30:2513–2516PubMedCrossRefGoogle Scholar
  12. 12.
    Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526PubMedCrossRefGoogle Scholar
  13. 13.
    Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329. doi:10.1056/NEJMoa0804656 PubMedCrossRefGoogle Scholar
  14. 14.
    Ciccone A, Valvassori L, Nichelatti M et al (2013) Endovascular treatment for acute ischemic stroke. N Engl J Med 368:904–913. doi:10.1056/NEJMoa1213701 PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Kidwell CS, Jahan R, Gornbein J et al (2013) A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 368:914–923. doi:10.1056/NEJMoa1212793 PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Broderick JP, Palesch YY, Demchuk AM et al (2013) Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368:893–903. doi:10.1056/NEJMoa1214300 PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Stroke Unit Trialists’ Collaboration (2013) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 9:CD000197. doi:10.1002/14651858.CD000197.pub3 Google Scholar
  18. 18.
    Wijdicks EFM, Sheth KN, Carter BS et al (2014) Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. doi:10.1161/01.str.0000441965.15164.d6 PubMedGoogle Scholar
  19. 19.
    Rowat AM, Dennis MS, Wardlaw JM (2006) Hypoxaemia in acute stroke is frequent and worsens outcome. Cerebrovasc Dis 21:166–172. doi:10.1159/000090528 PubMedCrossRefGoogle Scholar
  20. 20.
    Ronning OM, Guldvog B (1999) Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 30:2033–2037PubMedCrossRefGoogle Scholar
  21. 21.
    Ali K, Warusevitane A, Lally F et al (2013) The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke-effect on key outcomes at six months. PLoS ONE 8:e59274. doi:10.1371/journal.pone.0059274 PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Rincon F, Kang J, Maltenfort M et al (2014) Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med 42:387–396. doi:10.1097/CCM.0b013e3182a27732 PubMedCrossRefGoogle Scholar
  23. 23.
    Rout MW, Lane DJ, Wollner L (1971) Prognosis in acute cerebrovascular accidents in relation to respiratory pattern and blood gas tensions. Br Med J 3:7–9PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Pollock JM, Deibler AR, Whitlow CT et al (2009) Hypercapnia-induced cerebral hyperperfusion: an under recognized clinical entity. AJNR Am J Neuroradiol 30:378–385. doi:10.3174/ajnr.A1316 PubMedCrossRefGoogle Scholar
  25. 25.
    Bösel J (2014) Tracheostomy in stroke patients. Curr Treat Options Neurol 16:274PubMedCrossRefGoogle Scholar
  26. 26.
    Santoli F, De Jonghe B, Hayon J et al (2001) Mechanical ventilation in patients with acute ischemic stroke: survival and outcome at one year. Intensive Care Med 27:1141–1146PubMedCrossRefGoogle Scholar
  27. 27.
    Hamdy S, Aziz Q, Rothwell JC et al (1997) Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet 350:686–692. doi:10.1016/S0140-6736(97)02068-0 PubMedCrossRefGoogle Scholar
  28. 28.
    Bours G, Speyer R, Lemmens J (2009) Bedside screening tests vs. videofluoroscopy or fibreoptic endoscopic evaluation of swallowing to detect dysphagia in patients with neurological disorders: systematic review. J Adv Nurs 65:477–493PubMedCrossRefGoogle Scholar
  29. 29.
    Geeganage C, Beavan J, Ellender S, Bath PMW (2012) Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev 10:CD000323. doi:10.1002/14651858.CD000323.pub2 PubMedGoogle Scholar
  30. 30.
    Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA (2002) Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33:1315–1320PubMedCrossRefGoogle Scholar
  31. 31.
    Potter JF, Robinson TG, Ford GA et al (2009) Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 8:48–56. doi:10.1016/s1474-4422(08)70263-1 PubMedCrossRefGoogle Scholar
  32. 32.
    He J, Zhang Y, Xu T et al (2014) Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA 311:479–489. doi:10.1001/jama.2013.282543 PubMedCrossRefGoogle Scholar
  33. 33.
    Kaste M, Fogelholm R, Erila T et al (1994) A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 25:1348–1353PubMedCrossRefGoogle Scholar
  34. 34.
    Sandset EC, Bath PM, Boysen G et al (2011) The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 377:741–750. doi:10.1016/s0140-6736(11)60104-9 PubMedCrossRefGoogle Scholar
  35. 35.
    Rordorf G, Koroshetz WJ, Ezzeddine MA et al (2001) A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 56:1210–1213PubMedCrossRefGoogle Scholar
  36. 36.
    Asplund K (2002) Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev 4:CD000103. doi:10.1002/14651858.cd000103 PubMedGoogle Scholar
  37. 37.
    Ginsberg MD, Palesch YY, Hill MD et al (2013) High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol 12:1049–1058. doi:10.1016/S1474-4422(13)70223-0 PubMedCrossRefGoogle Scholar
  38. 38.
    Norris JW, Froggatt GM, Hachinski VC (1978) Cardiac arrhythmias in acute stroke. Stroke 9:392–396PubMedCrossRefGoogle Scholar
  39. 39.
    Kerr G, Ray G, Wu O et al (2009) Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 28:220–226. doi:10.1159/000226773 PubMedCrossRefGoogle Scholar
  40. 40.
    Darki A, Schneck MJ, Agrawal A et al (2013) Correlation of elevated troponin and echocardiography in acute ischemic stroke. J Stroke Cerebrovasc Dis 22:959–961. doi:10.1016/j.jstrokecerebrovasdis.2011.12.004 PubMedCrossRefGoogle Scholar
  41. 41.
    Sörös P, Hachinski V (2012) Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol 11:179–188. doi:10.1016/S1474-4422(11)70291-5 PubMedCrossRefGoogle Scholar
  42. 42.
    Alvarez-Sabin J, Molina CA, Montaner J et al (2003) Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 34:1235–1241. doi:10.1161/01.str.0000068406.30514.31 PubMedCrossRefGoogle Scholar
  43. 43.
    Southerland AM, Johnston KC (2012) Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. Ann N Y Acad Sci 1268:72–78. doi:10.1111/j.1749-6632.2012.06731.x PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Kase CS, Furlan AJ, Wechsler LR et al (2001) Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57:1603–1610PubMedCrossRefGoogle Scholar
  45. 45.
    Leigh R, Zaidat OO, Suri MF et al (2004) Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 35:1903–1907. doi:10.1161/01.STR.0000132571.77987.4c PubMedCrossRefGoogle Scholar
  46. 46.
    Uyttenboogaart M, Koch MW, Stewart RE et al (2007) Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 130:1626–1630. doi:10.1093/brain/awm087 PubMedCrossRefGoogle Scholar
  47. 47.
    Bellolio MF, Gilmore RM, Stead LG (2011) Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev 9:CD005346. doi:10.1002/14651858.CD005346.pub3 PubMedGoogle Scholar
  48. 48.
    Rosso C, Corvol J-C, Pires C et al (2012) Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke 43:2343–2349. doi:10.1161/STROKEAHA.112.657122 PubMedCrossRefGoogle Scholar
  49. 49.
    Wrotek SE, Kozak WE, Hess DC, Fagan SC (2011) Treatment of fever after stroke: conflicting evidence. Pharmacotherapy 31:1085–1091. doi:10.1592/phco.31.11.1085 PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Phipps MS, Desai RA, Wira C, Bravata DM (2011) Epidemiology and outcomes of fever burden among patients with acute ischemic stroke. Stroke 42:3357–3362. doi:10.1161/strokeaha.111.621425 PubMedCrossRefGoogle Scholar
  51. 51.
    den Hertog HM, van der Worp HB, van Gemert HM et al (2009) The paracetamol (acetaminophen) in stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 8:434–440. doi:10.1016/s1474-4422(09)70051-1 CrossRefGoogle Scholar
  52. 52.
    de Ridder IR, de Jong FJ, den Hertog HM et al (2013) Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): Protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 degrees C or above. Int J Stroke. doi:10.1111/ijs.12053 PubMedGoogle Scholar
  53. 53.
    Dippel DWJ, van Breda EJ, van der Worp HB et al (2003) Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]. BMC Cardiovasc Disord 3:2. doi:10.1186/1471-2261-3-2 PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Wu TC, Grotta JC (2013) Hypothermia for acute ischaemic stroke. Lancet Neurol 12:275–284. doi:10.1016/S1474-4422(13)70013-9 PubMedCrossRefGoogle Scholar
  55. 55.
    Hertog den HM, van der Worp HB, Tseng M-C, Dippel DW (2009) Cooling therapy for acute stroke. Cochrane Database Syst Rev CD001247. doi: 10.1002/14651858.CD001247.pub2
  56. 56.
    Meunier JM, Chang W-TW, Bluett B et al (2012) Temperature affects thrombolytic efficacy using rt-PA and eptifibatide, an in vitro study. Ther Hypothermia Temp Manag 2:112–118. doi:10.1089/ther.2012.0007 PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Choi HA, Badjatia N, Mayer SA (2012) Hypothermia for acute brain injury-mechanisms and practical aspects. Nat Rev Neurol 8:214–222. doi:10.1038/nrneurol.2012.21 PubMedGoogle Scholar
  58. 58.
    Harris B, Andrews PJ, Murray GD et al (2012) Systematic review of head cooling in adults after traumatic brain injury and stroke. Health Technol Assess 16:1–175. doi:10.3310/hta16450 Google Scholar
  59. 59.
    Bath PM, Iddenden R, Bath FJ (2000) Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 31:1770–1778PubMedCrossRefGoogle Scholar
  60. 60.
    Paciaroni M, Agnelli G, Micheli S, Caso V (2007) Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 38:423–430. doi:10.1161/01.STR.0000254600.92975.1f PubMedCrossRefGoogle Scholar
  61. 61.
    Bath P, Leonardi-Bee J, Bath F (2002) Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 11:55–62. doi:10.1053/jscd.2002.126694 PubMedCrossRefGoogle Scholar
  62. 62.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587. doi:10.1056/NEJM199512143332401 CrossRefGoogle Scholar
  63. 63.
    Sandercock PA, van den Belt AG, Lindley RI, Slattery J (1993) Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatr 56:17–25PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Sherman DG, Albers GW, Bladin C et al (2007) The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 369:1347–1355. doi:10.1016/S0140-6736(07)60633-3 PubMedCrossRefGoogle Scholar
  65. 65.
    Trials Collaboration CLOTS, Dennis M, Sandercock P et al (2013) The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2. Stroke 44:1075–1079. doi:10.1161/STROKEAHA.111.680298 CrossRefGoogle Scholar
  66. 66.
    Dennis M, Sandercock P, CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration et al (2013) Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet 382:516–524. doi:10.1016/S0140-6736(13)61050-8 PubMedCrossRefGoogle Scholar
  67. 67.
    Kellert L, Schrader F, Ringleb P et al (2013) The impact of low hemoglobin levels and transfusion on critical care patients with severe ischemic stroke: STroke: RelevAnt Impact of HemoGlobin, Hematocrit and Transfusion (STRAIGHT)-an observational study. J Crit Care. doi:10.1016/j.jcrc.2013.11.008 PubMedGoogle Scholar
  68. 68.
    LeRoux P (2013) Haemoglobin management in acute brain injury. Curr Opin Crit Care 19:83–91. doi:10.1097/MCC.0b013e32835eba43 PubMedCrossRefGoogle Scholar
  69. 69.
    Dexter F, Hindman BJ (1997) Effect of haemoglobin concentration on brain oxygenation in focal stroke: a mathematical modelling study. Br J Anaesth 79:346–351PubMedCrossRefGoogle Scholar
  70. 70.
    Furlan A, Higashida R, Wechsler L et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282:2003–2011PubMedCrossRefGoogle Scholar
  71. 71.
    Broderick JP (2009) Endovascular therapy for acute ischemic stroke. Stroke 40:S103–S106. doi:10.1161/strokeaha.108.533067 PubMedCrossRefGoogle Scholar
  72. 72.
    Kirkman MA, Smith M (2012) Multimodal intracranial monitoring: implications for clinical practice. Anesthesiol Clin 30:269–287. doi:10.1016/j.anclin.2012.05.007 PubMedCrossRefGoogle Scholar
  73. 73.
    Poca MA, Benejam B, Sahuquillo J et al (2010) Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful? J Neurosurg 112:648–657. doi:10.3171/2009.7.JNS081677 PubMedCrossRefGoogle Scholar
  74. 74.
    Rajajee V, Vanaman M, Fletcher JJ, Jacobs TL (2011) Optic nerve ultrasound for the detection of raised intracranial pressure. Neurocrit Care 15:506–515. doi:10.1007/s12028-011-9606-8 PubMedCrossRefGoogle Scholar
  75. 75.
    Unterberg AW, Kiening KL, Härtl R et al (1997) Multimodal monitoring in patients with head injury: evaluation of the effects of treatment on cerebral oxygenation. J Trauma 42:S32–S37PubMedCrossRefGoogle Scholar
  76. 76.
    Aries MJ, Coumou AD, Elting JW et al (2012) Near infrared spectroscopy for the detection of desaturations in vulnerable ischemic brain tissue: a pilot study at the stroke unit bedside. Stroke 43:1134–1136. doi:10.1161/strokeaha.111.636894 PubMedCrossRefGoogle Scholar
  77. 77.
    Highton D, Panovska-Griffiths J, Ghosh A et al (2013) Modelling cerebrovascular reactivity: a novel near-infrared biomarker of cerebral autoregulation? Adv Exp Med Biol 765:87–93. doi:10.1007/978-1-4614-4989-8_13 PubMedCrossRefGoogle Scholar
  78. 78.
    Lee JK, Kibler KK, Benni PB et al (2009) Cerebrovascular reactivity measured by near-infrared spectroscopy. Stroke 40:1820–1826. doi:10.1161/STROKEAHA.108.536094 PubMedCrossRefGoogle Scholar
  79. 79.
    Vespa P, Bergsneider M, Hattori N et al (2005) Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 25:763–774. doi:10.1038/sj.jcbfm.9600073 PubMedCrossRefGoogle Scholar
  80. 80.
    Schabitz WR, Berger C, Schellinger PD et al (2001) Neurometabolic changes during treatment with moderate hypothermia in a patient suffering from severe middle cerebral artery infarction. Cerebrovasc Dis 12:298–302PubMedCrossRefGoogle Scholar
  81. 81.
    Schneweis S, Grond M, Staub F et al (2001) Predictive value of neurochemical monitoring in large middle cerebral artery infarction. Stroke 32:1863–1867PubMedCrossRefGoogle Scholar
  82. 82.
    Kanthan R, Shuaib A, Griebel R et al (1996) Glucose-induced decrease in glutamate levels in ischemic human brain by in vivo microdialysis. Neurosci Lett 209:207–209PubMedCrossRefGoogle Scholar
  83. 83.
    Purkayastha S, Sorond F (2012) Transcranial Doppler ultrasound: technique and application. Semin Neurol 32:411–420. doi:10.1055/s-0032-1331812 PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Aries MJH, Elting JW, De Keyser J et al (2010) Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 41:2697–2704. doi:10.1161/STROKEAHA.110.594168 PubMedCrossRefGoogle Scholar
  85. 85.
    Vahedi K, Hofmeijer J, Juettler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215–222. doi:10.1016/s1474-4422(07)70036-4 PubMedCrossRefGoogle Scholar
  86. 86.
    Bereczki D, Fekete I, Prado GF, Liu M (2007) Mannitol for acute stroke. Cochrane Database Syst Rev 3:CD001153. doi:10.1002/14651858.CD001153.pub2 PubMedGoogle Scholar
  87. 87.
    Schwarz S, Georgiadis D, Aschoff A, Schwab S (2002) Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 33:136–140PubMedCrossRefGoogle Scholar
  88. 88.
    Schwarz S, Schwab S, Bertram M et al (1998) Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 29:1550–1555PubMedCrossRefGoogle Scholar
  89. 89.
    Kamel H, Navi BB, Nakagawa K et al (2011) Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 39:554–559. doi:10.1097/CCM.0b013e318206b9be PubMedCrossRefGoogle Scholar
  90. 90.
    Sandercock PA, Soane T (2011) Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2:CD000064. doi:10.1002/14651858.CD000064.pub2 Google Scholar
  91. 91.
    Beghi E, D’Alessandro R, Beretta S et al (2011) Incidence and predictors of acute symptomatic seizures after stroke. Neurology 77:1785–1793. doi:10.1212/WNL.0b013e3182364878 PubMedCrossRefGoogle Scholar
  92. 92.
    van Tuijl JH, van Raak EP, de Krom MC et al (2011) Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. Seizure 20:285–291. doi:10.1016/j.seizure.2010.12.012 PubMedCrossRefGoogle Scholar
  93. 93.
    Camilo O, Goldstein LB (2004) Seizures and epilepsy after ischemic stroke. Stroke 35:1769–1775. doi:10.1161/01.str.0000130989.17100.96 PubMedCrossRefGoogle Scholar
  94. 94.
    Claassen J, Taccone FS, Horn P et al (2013) Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med 39:1337–1351. doi:10.1007/s00134-013-2938-4 PubMedCrossRefGoogle Scholar
  95. 95.
    Huttner HB, Schwab S (2009) Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol 8:949–958. doi:10.1016/S1474-4422(09)70224-8 PubMedCrossRefGoogle Scholar
  96. 96.
    Briggs DE, Felberg RA, Malkoff MD, Bratina P (2001) Should mild or moderate stroke patients be admitted to an intensive care unit? Stroke 32:871–876PubMedCrossRefGoogle Scholar
  97. 97.
    van der Worp HB, Claus SP, Bär PR et al (2001) Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke 32:424–430PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2014

Authors and Affiliations

  • Matthew A. Kirkman
    • 1
    • 2
  • Giuseppe Citerio
    • 3
  • Martin Smith
    • 1
    • 4
  1. 1.Neurocritical Care Unit, The National Hospital for Neurology and NeurosurgeryUniversity College London HospitalsLondonUK
  2. 2.Faculty of MedicineImperial College LondonLondonUK
  3. 3.Neurointensive Care Unit, Department of Anaesthesia and Critical CareOspedale San GerardoMonzaItaly
  4. 4.NIHR University College London Hospitals Biomedical Research CentreLondonUK

Personalised recommendations